Updated:
Biomerics
Biomerics runs the largest CDMO in Costa Rica, vertically integrating medical plastics, micro metals, and automation for interventional OEMs.
Biomerics
Founded in Salt Lake City with a focus on complex interventional components, Biomerics has grown over 25 years into a full-service contract development and manufacturing organization (CDMO). The firm serves OEMs seeking to bring intricate devices to market by consolidating polymer processing, micro metals fabrication, and automation engineering within its own facilities rather than outsourcing across a fragmented supply chain. Biomerics covers the full manufacturing value chain from raw-polymer pellets through to finished, packaged interventional devices. Its physical capabilities span medical plastics — from large enclosures to microcomponents — alongside micro metals processing for robotic subsystems and device-level assembly. The firm’s two campuses in Costa Rica, which it describes as the country's largest and longest-running CDMO operation, provide a nearshore footprint that complements its Salt Lake City headquarters. This dual-geography model allows the company to tier projects between North American and Central American facilities depending on complexity, labor content, and customer logistics requirements. While Biomerics is privately held and does not disclose financial details, its April 2023 release noted its position as the "leading vertically integrated medical device contract manufacturer," implying meaningful scale in the interventional segment. The firm maintains engineering teams dedicated to material selection, design-for-manufacturability reviews, and automation integration — capabilities often reserved for in-house OEM groups rather than third-party contractors. In April 2026, the company issued a release suggesting continued capital deployment toward vertically integrated platform expansion. Biomerics' structural differentiator is the depth of its vertical integration in interventional manufacturing. Unlike pure-play component shops, the firm combines polymer science, micro-metals fabrication, and automation engineering within a single quality system, reducing handoffs that typically delay medtech launches. Its established Costa Rican footprint provides a regulatory-compliant nearshore alternative to Asian supply chains, a feature that became a differentiator for OEMs reevaluating geographic concentration.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Salt Lake City
Corporate office
6030 W Harold Gatty Dr., Salt Lake City, UT 84116, United States
Additional offices
Costa Rica
Sector focus
Frequently asked questions
Does Biomerics operate purely as a manufacturer, or does it provide design and engineering services?
Biomerics positions itself as an engineering partner that handles design-for-manufacturability reviews, material selection, and automation integration alongside physical production. Its website emphasizes proactive engineering of creative customer solutions, suggesting it gets involved well before the transfer-to-manufacturing stage for complex interventional components.
What is the significance of the Costa Rica operations to Biomerics' model?
The Costa Rica campuses represent a nearshore manufacturing hub that allows OEM customers to shift production out of Asia without moving all the way to the United States. Biomerics claims it is the largest and longest-operating CDMO in the country, which implies deep regulatory registrations, a trained workforce, and institutional knowledge of operating in a free-trade-zone environment serving U.S. and European medtech firms.
Which parts of the interventional device does Biomerics actually make?
The firm manufactures plastic components ranging from large enclosures to micro-scale parts, micro metal fabrications for robotic and device subsystems, and performs final device assembly. Its 'pellets to finished devices' description indicates it takes raw polymer feedstock and delivers packaged units, capturing the full bill of materials for many catheter-based and robotic interventional products.
Does Biomerics hold any public contracts or government relationships?
There is no publicly available information confirming government contracts or direct public-sector relationships. The firm's communications are exclusively oriented toward commercial OEM customers developing interventional products.
How does Biomerics' vertical integration model compare to traditional contract manufacturers?
Traditional medtech contract manufacturers often specialize in a single process — injection molding, machining, or cleanroom assembly — and OEMs must orchestrate multiple vendors. Biomerics consolidates polymer processing, micro metals fabrication, and automation engineering under one roof with a single quality system, which reduces the integration risk and project-management overhead that fragmented supply chains create.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: